Venable Fitzpatrick successfully defended the validity of a compound patent covering Sanofi’s Jevtana (cabazitaxel) chemotherapy product before the Federal Circuit. Venable Fitzpatrick also succeeded in vacating…
Sanofi scores double win in Federal Circuit on Jevtana patents
